Interpace Biosciences Announces Fourth Quarter and Full Year 2025 Financial and Business Results

Q4 and FY Revenue of $9.2 million and $38.7 millionQ4 and FY Income from Continuing Operations of $22.8 million and $25.0 million (benefiting ...
Las Vegas Sun

Viridian Therapeutics Announces Positive Topline Results from Elegrobart Phase 3 REVEAL‑1 Clinical Trial in Active Thyroid Eye Disease

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today ...
The Lancet

Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement

eDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA fHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA gDepartment of ...

A thyroid problem babies are born with: Why early testing can change everything

The thyroid is a small gland present in the neck that produces hormones which are essential for growth, brain development, ...